EVOLUCIÓN DEL MANEJO ENDOVASCULAR EN MALFORMACIONES ARTERIOVENOSAS CEREBRALES

Autores/as

  • Carlos Fernando Lozano-Tangua Neurocirujano endovascular
  • Dr Zenteno Servicio de Terapia Endovascular Neurológica. Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"
  • Dr Lee Servicio de Terapia Endovascular Neurológica. Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"
  • Alfredo Casasco Servicio de Terapéutica Endovascular. Instituto de Neurociencias Avanzadas de Madrid. Clínica Nuestra Señora del Rosario.
  • Dr. Balderrama Servicio de Terapia Endovascular Neurológica. Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"
  • Juan Carlos Rosero Rosero Unidad de Hemodinamia. Hospital Universitario Departamental de Nariño.
  • Hernán Mauricio Patiño Rodriguez Unidad de Hemodinamia. Clínica Universitaria Colombia - Colsanitas
  • Dr. Montenegro. Unidad de Terapia Endovasular Neurológica. Instituto Nacional de Neurología y Neurocirugía de México "Manuel Velasco Suarez"
  • Dr Acosta. Unidad de Terapia Endovascular Neurológica. Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"
  • Dr. Ramirez. Unidad de Terapia Endovascular Neurológica. Instituto Nacional de Neurología y Neurocirugía "Manuel Velasco Suarez"

DOI:

https://doi.org/10.51437/nj.v28i1.183

Palabras clave:

Malformación arteriovenosa, embolización, endovascular, neurointervencionismo, líquidos embolizantes.

Resumen

Las malformaciones arteriovenosas (MAV’s) del sistema nervioso central (SNC) son un tipo de cortocircuito arteriovenoso que afecta a 1 de cada 100.000 habitantes y debuta principalmente antes de los 40 años. Diferentes presentaciones clínicas pueden retrasar el diagnóstico acertado: crisis convulsivas focales o generalizadas, deterioro súbito por hemorragia intra cerebral, cefalea y déficit neurológico progresivo secundario a fenómenos de robo vascular, son las principales manifestaciones clínicas con diferentes grados de deterioro funcional. Constituye un verdadero reto diagnóstico y terapéutico para el personal sanitario. Se requiere de un abordaje diagnóstico protocolizado, incluyendo: estado clínico basal, evaluación neuropsicológica, estudios de imágenes avanzadas de resonancia nuclear magnética (RNM), angiografía por sustracción digital (DSA, por su sigla en inglés), microcateterismos supraselectivos y pruebas evocativas, de ser necesario. Una vez establecido el diagnóstico, clasificado el grado en al menos tres escalas, y determinados los factores de riesgo de sangrado o resangrado, es posible considerar y ejecutar la mejor estrategia terapéutica para cada caso. El neurointervencionismo ha evolucionado a pasos agigantados en los últimos decenios, pasando de un rol meramente diagnóstico a ser una opción de tratamiento curativo por sí misma. En esta revisión se exponen aspectos básicos de la epidemiología, historia natural de la enfermedad, angioarquitectura, clasificaciones, toma de decisiones terapéuticas y manejo endovascular desde los inicios hasta la actualidad.

Citas

1. Mandybur TI, Nazek M. Cerebral arteriovenous malformations. A detailed morphological and immunohistochemical study using actin. Arch Pathol Lab Med. 1990;114(9):970–3.
2. Zuccaro G, Argañaraz R, Villasante F, Ceciliano A. Patología vascular en pacientes menores de un año. Rev Argentina Neurocir. 2009;
3. Rodesch G, Malherbe V, Alvarez H, Zerah M, Devictor D, Lasjaunias P. Nongalenic cerebral arteriovenous malformations in neonates and infants. Review of 26 consecutive cases (1982-1992). Childs Nerv Syst [Internet]. 1995 Apr;11(4):231–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/7621485
4. Morales-Valero SF, Bortolotti C, Sturiale C, Lanzino G. Are parenchymal AVMs congenital lesions? Neurosurg Focus [Internet]. 2014 Sep;37(3):E2. Available from: http://thejns.org/doi/10.3171/2014.6.FOCUS14234
5. Dalton A, Dobson G, Prasad M, Mukerji N. De novo intracerebral arteriovenous malformations and a review of the theories of their formation. Br J Neurosurg [Internet]. 2018;32(3):305–11. Available from: https://doi.org/10.1080/02688697.2018.1478060
6. Luessenhop AJ, Spence WT. Artificial embolization of cerebral arteries: Report of use in a case of arteriovenous malformation. J Am Med Assoc. 1960;172(11):1153–5.
7. Steiner L, Leksell L, Greitz T, Forster DM, Backlund EO. Stereotaxic radiosurgery for cerebral arteriovenous malformations. Report of a case. Acta Chir Scand [Internet]. 1972;138(5):459–64. Available from: http://www.ncbi.nlm.nih.gov/pubmed/4560250
8. Solomon RA, Connolly ES. Arteriovenous Malformations of the Brain. Ropper AH, editor. N Engl J Med [Internet]. 2017 May 11;376(19):1859–66. Available from: http://www.nejm.org/doi/10.1056/NEJMra1607407
9. Berman MF, Sciacca RR, Pile-Spellman J, Stapf C, Connolly ES, Mohr JP, et al. The epidemiology of brain arteriovenous malformations. Vol. 47, Neurosurgery. 2000. p. 389–97.
10. Hofmeister C, Stapf C, Hartmann A, Sciacca RR, Mansmann U, TerBrugge K, et al. Demographic, morphological, and clinical characteristics of 1289 patients with brain arteriovenous malformation. Stroke. 2000;31(6):1307–10.
11. McCormick WF. Pathology of vascular malformations of the brain. Wilson CB, Stein BM, editors. Baltomore: William & Wilkins; 1984. 84 p.
12. Larios C, Mimenza Alvarado A, Zenteno M, Murillo-Bonilla L, Sánchez Hernández J, García Ramos G, et al. Comportamiento de las malformaciones arteriovensosas cerebrales: Estudio de una cohorte de 302 pacientes. Rev Mex Neurocienc. 2010;11(5):330–7.
13. Hartmann A, Mast H, Mohr JP, Koennecke H-C, Osipov A, Pile-Spellman J, et al. Morbidity of Intracranial Hemorrhage in Patients With Cerebral Arteriovenous Malformation. Stroke [Internet]. 1998 May 1;29(5):931–4. Available from: http://stroke.ahajournals.org/cgi/doi/10.1161/01.STR.29.5.931
14. Josephson CB, Leach J-P, Duncan R, Roberts RC, Counsell CE, Al-Shahi Salman R. Seizure risk from cavernous or arteriovenous malformations: Prospective population-based study. Neurology [Internet]. 2011 May 3;76(18):1548–54. Available from: http://www.neurology.org/cgi/doi/10.1212/WNL.0b013e3182190f37
15. Morgan M, Winder M. Haemodynamics of arteriovenous malformations of the brain and consequences of resection: a review. J Clin Neurosci [Internet]. 2001 May;8(3):216–24. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0967586800907951
16. Diren F, Sencer S, Hakan T. Case Report of an Obstructive Hydrocephalus Caused by an Unruptured Mesencephalic Arteriovenous Malformation in a Boy and a Review of Literature. Open Neuroimag J [Internet]. 2018 Feb 21;12(1):10–5. Available from: http://benthamopen.com/FULLTEXT/TONIJ-12-10
17. Viñuela F, Fox AJ, Pelz DM, Drake CG. Unusual clinical manifestations of dural arteriovenous malformations. J Neurosurg [Internet]. 1986 Apr;64(4):554–8. Available from: http://thejns.org/doi/10.3171/jns.1986.64.4.0554
18. Diaz-Victoria AR, Idrovo Velandia ÁJ. Perfil neuropsicológico en pacientes con malformaciones arteriovenosas. Rev Mex Neurocienc [Internet]. 2006;7(6):550–7. Available from: http://www.medigraphic.com/pdfs/revmexneu/rmn-2006/rmn066f.pdf
19. Graf CJ, Perret GE, Torner JC. Bleeding from cerebral arteriovenous malformations as part of their natural history. J Neurosurg [Internet]. 1983;58(3):331–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/6827317
20. Ondra SL, Troupp H, George ED, Schwab K. The natural history of symptomatic arteriovenous malformations of the brain: a 24-year follow-up assessment. J Neurosurg [Internet]. 1990;73(3):387–91. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2384776
21. Gross BA, Du R. Natural history of cerebral arteriovenous malformations: a meta-analysis. J Neurosurg [Internet]. 2013;118(2):437–43. Available from: http://thejns.org/doi/10.3171/2012.10.JNS121280
22. da Costa L, Wallace MC, ter Brugge KG, O’Kelly C, Willinsky RA, Tymianski M. The Natural History and Predictive Features of Hemorrhage From Brain Arteriovenous Malformations. Stroke [Internet]. 2009 Jan 1;40(1):100–5. Available from: http://stroke.ahajournals.org/cgi/doi/10.1161/STROKEAHA.108.524678
23. Halim AX, Johnston SC, Singh V, McCulloch CE, Bennett JP, Achrol AS, et al. Longitudinal risk of intracranial hemorrhage in patients with arteriovenous malformation of the brain within a defined population. Stroke. 2004;35(7):1697–702.
24. Stapf C, Mast H, Sciacca RR, Choi JH, Khaw A V., Connolly ES, et al. Predictors of hemorrhage in patients with untreated brain arteriovenous malformation. Neurology. 2006;66(9):1350–5.
25. Redekop G, TerBrugge K, Montanera W, Willinsky R. Arterial aneurysms associated with cerebral arteriovenous malformations: classification, incidence, and risk of hemorrhage. J Neurosurg. 1998;89(4):539–46.
26. Kim H, Al-Shahi Salman R, McCulloch CE, Stapf C, Young WL. Untreated brain arteriovenous malformation: Patient-level meta-analysis of hemorrhage predictors. Neurology [Internet]. 2014 Aug 12;83(7):590–7. Available from: http://www.neurology.org/cgi/doi/10.1212/WNL.0000000000000688
27. Feliciano CE, de León-Berra R, Hernández-Gaitán MS, Rodríguez-Mercado R. A proposal for a new arteriovenous malformation grading scale for neuroendovascular procedures and literature review. P R Health Sci J [Internet]. 2010 Jun;29(2):117–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20496526
28. Can A, Gross BA, Du R. The natural history of cerebral arteriovenous malformations [Internet]. 1st ed. Vol. 143, Handbook of Clinical Neurology. Elsevier B.V.; 2017. 15–24 p. Available from: http://dx.doi.org/10.1016/B978-0-444-63640-9.00002-3
29. Van Beijnum J, Lovelock CE, Cordonnier C, Rothwell PM, Klijn CJM, Al-Shahi Salman R, et al. Outcome after spontaneous and arteriovenous malformation-related intracerebral haemorrhage: Population-based studies. Brain. 2009;132(2):537–43.
30. Liew JA, Yang W, Mashouf LA, Li S, Caplan JM, Tamargo RJ, et al. Incidence of Spontaneous Obliteration in Untreated Brain Arteriovenous Malformations. Neurosurgery. 2020;86(1):139–47.
31. Pascual B, Lagares A, Miranda P, Pérez-Nuñez A, Arrese I, Lobato RD, et al. Regresión espontánea de las malformaciones arteriovenosas cerebrales: presentación de un caso y revisión de la literatura. Neurocirugia. 2007;18(4):326–9.
32. Nas OF, Ozturk K, Gokalp G, Hakyemez B. Spontaneous occlusion of cerebral arteriovenous malformation following partial embolization with Onyx. Neuroradiol J [Internet]. 2017 Feb 6;30(1):96–8. Available from: http://journals.sagepub.com/doi/10.1177/1971400916678247
33. McCormick WF. The Pathology of Vascular (“Arteriovenous”) Malformations. J Neurosurg [Internet]. 1966 Apr;24(4):807–16. Available from: http://thejns.org/doi/10.3171/jns.1966.24.4.0807
34. Awad IA, Robinson JR, Mohanty S, Estes ML. Mixed vascular malformations of the brain: Clinical and pathogenetic considerations. Neurosurgery. 1993;33(2):179–88.
35. Lasjaunias P, Manelfe C, Chiu M. Angiographic architecture of intracranial vascular malformations and fistulas - pretherapeutic aspects. Neurosurg Rev. 1986;9(4):253–63.
36. Houdart E, Gobin YP, Casasco A, Aymard A, Herbreteau D, Merland JJ. A proposed angiographic classification of intracranial arteriovenous fistulae and malformations. Neuroradiology. 1993;35(5):381–5.
37. Hacein-Bey L, Young WL. Hemodynamic perturbations in cerebral arteriovenous malformations and management implications. Interv Neuroradiol [Internet]. 1999;5(SUPPL. 1):177–82. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L30006447
38. Busch KJ, Kiat H, Stephen M, Simons M, Avolio A, Morgan MK. Cerebral hemodynamics and the role of transcranial Doppler applications in the assessment and management of cerebral arteriovenous malformations. J Clin Neurosci [Internet]. 2016 Aug;30:24–30. Available from: http://www.sciencedirect.com/science/article/pii/S0967586816000825
39. Yasargil MG. Microneurosurgery. Part IIIA. New-York: Thieme medical publishers Inc; 1987.
40. Yasargil M. The concept of compartments. In: Inc TMP, editor. Microneurosurgery Part IIIA. New-York; 1987. p. 74–84.
41. Sheng L, Li J, Li H, Li G, Chen G, Xiang W, et al. Evaluation of cerebral arteriovenous malformation using “dual vessel fusion” technology. J Neurointerv Surg [Internet]. 2014;6(9):667–71. Available from: http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=PubMed&dopt=Citation&list_uids=24235097
42. Escobar-de la Garma V, Zenteno M, Padillla F, Ceron A, Balderrama J, Lee A. Evaluación integral de la angioarquitectura de los compartimentos nidales de malformaciones arteriovenosas cerebrales utilizando maniobras de compresión carotídea externa y tecnología de fusión dual de volúmenes tridimensionales. In: XXVII Congreso de la Sociedad Iberolatinoamericana de Neurorradiología Diagnóstica y Terapéutica [Internet]. Santiago de Compostela; 2015. p. 39. Available from: http://www.silan2015.org/wp-content/uploads/2015/07/LIBRO-COMUNICACIONES.pdf
43. Spetzler RF, Martin NA. A proposed grading system for arteriovenous malformations. J Neurosurg [Internet]. 1986;65(4):476–83. Available from: http://thejns.org/doi/10.3171/jns.1986.65.4.0476
44. Spetzler RF, Ponce F a. A 3-tier classification of cerebral arteriovenous malformations. Clinical article. J Neurosurg. 2011;114(3):842–9.
45. Saatci I, Geyik S, Yavuz K, Cekirge HS. Endovascular treatment of brain arteriovenous malformations with prolonged intranidal Onyx injection technique: long-term results in 350 consecutive patients with completed endovascular treatment course. J Neurosurg [Internet]. 2011;115(1):78–88. Available from: http://thejns.org/doi/10.3171/2011.2.JNS09830
46. Renieri L, Consoli A, Scarpini G, Grazzini G, Nappini S, Mangiafico S. Double arterial catheterization technique for embolization of brain arteriovenous malformations with onyx. Neurosurgery. 2013;72(1):92–8.
47. Pollock BE, Link MJ, Brown RD. The Risk of Stroke or Clinical Impairment After Stereotactic Radiosurgery for ARUBA-Eligible Patients. Stroke [Internet]. 2013 Feb 1;44(2):437–41. Available from: http://stroke.ahajournals.org/cgi/doi/10.1161/STROKEAHA.112.670232
48. Lawton MT, Kim H, McCulloch CE, Mikhak B, Young WL. A supplementary grading scale for selecting patients with brain arteriovenous malformations for surgery. Neurosurgery. 2010;66(4):702–13.
49. Nisson PL, Fard SA, Walter CM, Johnstone CM, Mooney MA, Meybodi AT, et al. A novel proposed grading system for cerebellar arteriovenous malformations. J Neurosurg. 2020;132(4):1105–15.
50. Lopes DK, Moftakhar R, Straus D, Munich SA, Chaus F, Kaszuba MC. Arteriovenous malformation embocure score: AVMES. J Neurointerv Surg [Internet]. 2016 Jul;8(7):685–91. Available from: http://jnis.bmj.com/lookup/doi/10.1136/neurintsurg-2015-011779
51. Dumont T, Kan P, Snyder K, Hopkins Ln, Siddiqui A, Levy E. A proposed grading system for endovascular treatment of cerebral arteriovenous malformations: Buffalo score. Surg Neurol Int [Internet]. 2015;6(1):3. Available from: http://surgicalneurologyint.com/surgicalint-articles/a-proposed-grading-system-for-endovascular-treatment-of-cerebral-arteriovenous-malformations-buffalo-score-2/
52. Pollock BE, Flickinger JC. A proposed radiosurgery-based grading system for arteriovenous malformations. J Neurosurg [Internet]. 2002 Jan;96(1):79–85. Available from: http://thejns.org/doi/10.3171/jns.2002.96.1.0079
53. Del Valle R, Zenteno M, Jaramillo J, Lee A, De Anda S. Definition of the key target volume in radiosurgical management of arteriovenous malformations: a new dynamic concept based on angiographic circulation time. J Neurosurg. 2008;109 Suppl(December):41–50.
54. Derdeyn CP, Zipfel GJ, Albuquerque FC, Cooke DL, Feldmann E, Sheehan JP, et al. Management of Brain Arteriovenous Malformations: A Scientific Statement for Healthcare Professionals From the American Heart Association/American Stroke Association. Stroke [Internet]. 2017 Aug;48(8):e200–24. Available from: http://stroke.ahajournals.org/lookup/doi/10.1161/STR.0000000000000134
55. Mohr JP, Parides MK, Stapf C, Moquete E, Moy CS, Overbey JR, et al. Medical management with or without interventional therapy for unruptured brain arteriovenous malformations (ARUBA): a multicentre, non-blinded, randomised trial. Lancet [Internet]. 2014 Feb;383(9917):614–21. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0140673613623028
56. Cognard C. A randomized trial of unruptured brain arteriovenous malformations study: What impact on clinical care and therapeutic decision? American Journal of Neuroradiology. 2015;36(4):619–22.
57. Mohr JP, Overbey JR, Hartmann A, Kummer R von, Al-Shahi Salman R, Kim H, et al. Medical management with interventional therapy versus medical management alone for unruptured brain arteriovenous malformations (ARUBA): final follow-up of a multicentre, non-blinded, randomised controlled trial. Lancet Neurol [Internet]. 2020;19(7):573–81. Available from: http://dx.doi.org/10.1016/S1474-4422(20)30181-2
58. Darsaut TE, Magro E, Gentric JC, Batista AL, Chaalala C, Roberge D, et al. Treatment of Brain AVMs (TOBAS): Study protocol for a pragmatic randomized controlled trial. Trials. 2015;16(1):1–12.
59. Morgan MK, Davidson AS, Assaad NNA, Stoodley MA. Critical review of brain AVM surgery, surgical results and natural history in 2017. Acta Neurochir (Wien) [Internet]. 2017 Aug 29;159(8):1457–78. Available from: http://link.springer.com/10.1007/s00701-017-3217-x
60. Rutledge WC, Abla AA, Nelson J, Halbach V V., Kim H, Lawton MT. Treatment and outcomes of ARUBA-eligible patients with unruptured brain arteriovenous malformations at a single institution. Neurosurg Focus. 2014;37(3):3–7.
61. Link TW, Winston G, Schwarz JT, Lin N, Patsalides A, Gobin P, et al. Treatment of Unruptured Brain Arteriovenous Malformations: A Single-Center Experience of 86 Patients and a Critique of the A Randomized Trial of Unruptured Brain Arteriovenous Malformations (ARUBA) Trial. World Neurosurg [Internet]. 2018;120:e1156–62. Available from: https://doi.org/10.1016/j.wneu.2018.09.025
62. Padilla-Vazquez F, Zenteno M, Balderrama J, Escobar-de la Garma V, Juan D, Trenado C. A proposed classification for assessing rupture risk in patients with intracranial arteriovenous malformations. Surg Neurol Int [Internet]. 2017;8(1):303. Available from: http://surgicalneurologyint.com/wp-content/uploads/2018/01/8706/SNI-8-303.pdf
63. Feliciano CE, De León-Berra R, Hernández-Gaitán MS, Torres HM, Creagh O, Rodríguez-Mercado R. Provocative test with propofol: Experience in patients with cerebral arteriovenous malformations who underwent neuroendovascular procedures. Am J Neuroradiol. 2010;31(3):470–5.
64. Shenkin HA, Spitz EB, Grant FC, Kety SS. Physiologic Studies of Arteriovenous Anomalies of the Brain. J Neurosurg [Internet]. 1948 Mar;5(2):165–72. Available from: http://thejns.org/doi/10.3171/jns.1948.5.2.0165
65. Weber W, Kis B, Siekmann R, Jans P, Laumer R, Kühne D. Preoperative embolization of intracranial arteriovenous malformations with Onyx. Neurosurgery. 2007;61(2):244–52.
66. Paul L, Casasco A, Kusak ME, Martínez N, Rey G, Martínez R. Results for a series of 697 Arteriovenous malformations treated by gamma knife: Influence of angiographic features on the obliteration rate. Neurosurgery. 2014;75(5):568–82.
67. Richling B, Killer M, Al-Schameri AR, Ritter L, Agic R, Krenn M. Therapy of Brain Arteriovenous Malformations: Multimodality Treatment from a Balanced Standpoint. Neurosurgery [Internet]. 2006 Nov 1;59(suppl_5):S3-148-S3-157. Available from: https://academic.oup.com/neurosurgery/article/59/suppl_5/S3-148/2558519
68. Nataraj A, Mohamed MB, Gholkar A, Vivar R, Watkins L, Aspoas R, et al. Multimodality Treatment of Cerebral Arteriovenous Malformations. World Neurosurg [Internet]. 2014 Jul;82(1–2):149–59. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23454686
69. Crowley RW, Ducruet AF, McDougall CG, Albuquerque FC. Endovascular Advances for Brain Arteriovenous Malformations. Neurosurgery [Internet]. 2014 Feb;74(2 SUPPL.):S74–82. Available from: https://academic.oup.com/neurosurgery/article-lookup/doi/10.1227/NEU.0000000000000176
70. Serbinenko FA. Balloon catheterization and occlusion of major cerebral vessels. J Neurosurg [Internet]. 1974;41(2):125–45. Available from: http://thejns.org/doi/10.3171/jns.1974.41.2.0125
71. Kerber C. Letter: Intracranial cyanoacrylate: a new catheter therapy for arteriovenous malformation. Invest Radiol [Internet]. 1975;10(5):536–8. Available from: http://www.ncbi.nlm.nih.gov/pubmed/1205714
72. Rufenacht D, Merland JJ. A new and original microcatheter system for hyperselective catheterization and endovascular treatment without risk of arterial rupture. J Neuroradiol [Internet]. 1986;13(1):44–54. Available from: http://www.ncbi.nlm.nih.gov/pubmed/3746438
73. Kikuchi Y, Strother CM, Boyer M. New catheter for endovascular interventional procedures. Radiology. 1987;165(3):870–1.
74. Beaujeux R, Laurent A, Wassef M, Casasco A, Gobin YP, Aymard A, et al. Trisacryl gelatin microspheres for therapeutic embolization, II: Preliminary clinical evaluation in tumors and arteriovenous malformations. Am J Neuroradiol. 1996;17(3):541–8.
75. Vaidya S, Tozer KR, Chen J. An overview of embolic agents. Vol. 25, Seminars in Interventional Radiology. 2008. p. 204–15.
76. Brothers MF, Kaufmann JCE, Fox AJ, Deveikis JP. n-Butyl 2-cyanoacrylate - substitute for IBCA in interventional neuroradiology: histopathologic and polymerization time studies. Am J Neuroradiol. 1989;10(4):777–86.
77. Deruty R, Pelissou-Guyotat I, Mottolese C, Bascoulergue Y, Amat D. The combined management of cerebral arteriovenous malformations experience with 100 cases and review of the literature. Vol. 123, Acta Neurochirurgica. 1993. p. 101–12.
78. Lundqvist C, Wikholm G, Svendsen P. Embolization of cerebral arteriovenous malformations: Part II--Aspects of complications and late outcome. Neurosurgery [Internet]. 1996;39(3):460–7; discussion 467-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/8875475
79. Vinuela F, Duckwiler G, Guglielmi G. Contribution of interventional neuroradiology in the therapeutic management of brain arteriovenous malformations. J Stroke Cerebrovasc Dis. 1997;6(4):268–71.
80. Gobin YP, Laurent A, Merienne L, Schlienger M, Aymard A, Houdart E, et al. Treatment of brain arteriovenous malformations by embolization and radiosurgery. J Neurosurg [Internet]. 1996 Jul;85(1):19–28. Available from: http://thejns.org/doi/10.3171/jns.1996.85.1.0019
81. Deruty R, Pelissou-Guyotat I, Morel C, Bascoulergue Y, Turjman F. Reflections on the management of cerebral arteriovenous malformations. Surg Neurol. 1998;50(3):245–6.
82. Valavanis A, Yasargil MG. The endovascular treatment of brain arteriovenous malformations. Adv Tech Stand Neurosurg [Internet]. 1998;24:131–214. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10050213
83. Taki W, Yonekawa Y, Iwata H, Uno A, Yamashita K, Amemiya H. A new liquid material for embolization of arteriovenous malformations. Am J Neuroradiol. 1990;11(1):163–8.
84. Loh Y, Duckwiler GR. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article. J Neurosurg [Internet]. 2010;113(4):733–41. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20433277
85. Perez-Higueras A, Rossi Lopez R, Quinones Tapia D. Endovascular Treatment of Cerebral AVM: Our Experience with Onyx. Interv Neuroradiol [Internet]. 2005;11(Suppl 1):141–57. Available from: http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3404756/%5Cnfiles/2981/Perez-Higueras i in. - 2005 - Endovascular Treatment of Cerebral AVM Our Experi.pdf%5Cnhttp://www.ncbi.nlm.nih.gov/pubmed/20584469
86. Panagiotopoulos V, Gizewski E, Asgari S, Regel J, Forsting M, Wanke I. Embolization of intracranial arteriovenous malformations with ethylene-vinyl alcohol copolymer (Onyx). Am J Neuroradiol. 2009;30(1):99–106.
87. Mounayer C, Hammami N, Piotin M, Spelle L, Benndorf G, Kessler I, et al. Nidal embolization of brain arteriovenous malformations using onyx in 94 patients. Am J Neuroradiol. 2007;28(3):518–23.
88. Katsaridis V, Papagiannaki C, Aimar E. Curative embolization of cerebral arteriovenous malformations (AVMs) with Onyx in 101 patients. Neuroradiology. 2008;50(7):589–97.
89. Akmangit I, Daglioglu E, Kaya T, Alagoz F, Sahinoglu M, Peker A, et al. Preliminary experience with Squid: A new liquid embolizing agent for AVM, AV fistulas and tumors. Turk Neurosurg. 2014;24(4):565–70.
90. Sirakov S, Sirakov A, Minkin K, Penkov M, Ninov K, Hristov H, et al. Initial experience with the new ethylene vinyl alcohol copolymer based liquid embolic agent Menox in the endovascular treatment of cerebral arteriovenous malformations. J Neurointerv Surg. 2019;11(10):1040–4.
91. Lamin S, Chew HS, Chavda S, Thomas A, Piano M, Quilici L, et al. Embolization of intracranial dural arteriovenous fistulas using PHIL liquid embolic agent in 26 patients: A multicenter study. Am J Neuroradiol. 2017;38(1):127–31.
92. Samaniego EA, Kalousek V, Abdo G, Ortega-Gutierrez S. Preliminary experience with Precipitating Hydrophobic Injectable Liquid (PHIL) in treating cerebral AVMs. J Neurointerv Surg. 2016;8(12):1253–5.
93. Koçer N, Hanımoğlu H, Batur Ş, Kandemirli SG, Kızılkılıç O, Sanus Z, et al. Preliminary experience with precipitating hydrophobic injectable liquid in brain arteriovenous malformations. Diagn Interv Radiol [Internet]. 22(2):184–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/26782157
94. Leonardi M, Barbara C, Simonetti L, Giardino R, Aldini NN, Fini M, et al. Glubran 2®:A New Acrylic Glue for Neuroradiological Endovascular Use A Complementary Histological Study. Interv Neuroradiol [Internet]. 2003;9:249–54. Available from: http://www.pubmedcentral.nih.gov/articlerender.fcgi?artid=3572477&tool=pmcentrez&rendertype=abstract
95. Raffi L, Simonetti L, Cenni P, Leonardi M. Use of Glubran 2 acrylic glue in interventional neuroradiology. Neuroradiology. 2007;49(10):829–36.
96. Izaaryene J, Saeed Kilani M, Rolland PH, Gaubert JY, Jacquier A, Bartoli JM, et al. Preclinical study on an animal model of a new non-adhesive cyanoacrylate (Purefill®) for arterial embolization. Diagn Interv Imaging [Internet]. 2016;97(11):1109–16. Available from: http://dx.doi.org/10.1016/j.diii.2016.05.013
97. Kulcsár Z, Karol A, Kronen PW, Svende P, Klein K, Jordan O, et al. A novel, non-adhesive, precipitating liquid embolic implant with intrinsic radiopacity: feasibility and safety animal study. Eur Radiol [Internet]. 2017 Mar 14;27(3):1248–56. Available from: http://link.springer.com/10.1007/s00330-016-4463-7
98. Sirakov A, Minkin K, Sirakov S. Intermixed dimethyl-sulfoxide–based nonadhesive liquid embolic agents delivered serially via the same microcatheter for cerebral AVM treatment. Am J Neuroradiol. 2020;41(4):681–6.
99. Maimon S, Strauss I, Frolov V, Margalit N, Ram Z. Brain Arteriovenous Malformation Treatment Using a Combination of Onyx and a New Detachable Tip Microcatheter, SONIC: Short-Term Results. Am J Neuroradiol [Internet]. 2010 May 1;31(5):947–54. Available from: http://www.ajnr.org/cgi/doi/10.3174/ajnr.A1959
100. Chapot R, Stracke P, Velasco A, Nordmeyer H, Heddier M, Stauder M, et al. The Pressure Cooker Technique for the treatment of brain AVMs. J Neuroradiol. 2014;41(1):87–91.
101. Zhang G, Zhu S, Wu P, Xu S SH. The transvenous pressure cooker technique: A treatment for brain arteriovenous malformations. Interv Neuroradiol [Internet]. 2017;23(2):194–9. Available from: http://www.embase.com/search/results?subaction=viewrecord&from=export&id=L615732178%5Cnhttp://dx.doi.org/10.1177/1591019916682357%5Cnhttp://vu.on.worldcat.org/atoztitles/link?sid=EMBASE&issn=15910199&id=doi:10.1177%2F1591019916682357&atitle=The+transvenou
102. Lopes DK, Bagan B, Wells K. Onyx embolization of arteriovenous malformations using 2 microcatheters. Neurosurgery. 2010;66(3):616–8.
103. Abud DG, Riva R, Nakiri GS, Padovani F, Khawaldeh M, Mounayer C. Treatment of brain arteriovenous malformations by double arterial catheterization with simultaneous injection of Onyx: Retrospective series of 17 patients. Am J Neuroradiol. 2011;32(1):152–8.
104. Cekirge S, Saatci I. Advance Curative Transarterial AVM Treatment With Multiplug Intranidal Flow Control Technique. In 2019. p. 1–19. Available from: www.esnr.org
105. Zhao W-Y, Krings T, Yang P-F, Liu J-M, Xu Y, Li Q, et al. Balloon-Assisted Superselective Microcatheterization for Transarterial Treatment of Cranial Dural Arteriovenous Fistulas. Oper Neurosurg [Internet]. 2012 Dec;71(SUPPL.2):ons269–73. Available from: https://academic.oup.com/ons/article-lookup/doi/10.1227/NEU.0b013e3182684b70
106. Mendes GAC, Silveira EP, Saleme S, Iosif C, Ponomarjova S, Caire F, et al. Balloon-assisted microcatheter navigation for AVM embolization: technical note. J Neurosurg [Internet]. 2015 Nov;123(5):1120–4. Available from: http://thejns.org/doi/10.3171/2014.10.JNS141359
107. Orozco LD, Luzardo GD, Buciuc RF. Transarterial balloon assisted Onyx embolization of pericallosal arteriovenous malformations. J Neurointerv Surg [Internet]. 2013 Jul;5(4):e18–e18. Available from: http://jnis.bmj.com/lookup/doi/10.1136/neurintsurg-2012-010388
108. Jagadeesan BD, Grigoryan M, Hassan AE, Grande AW, Tummala RP. Endovascular Balloon-Assisted Embolization of Intracranial and Cervical Arteriovenous Malformations Using Dual-Lumen Coaxial Balloon Microcatheters and Onyx. Oper Neurosurg [Internet]. 2013 Dec;73(SUPPL. 2):ons238–43. Available from: https://academic.oup.com/ons/article-lookup/doi/10.1227/NEU.0000000000000186
109. ApSimon HT, Khangure MS. Improved technique of bucrylate embolisation in brain arteriovenous malformation. The use of additional temporary balloon occlusion. Acta Radiol Suppl [Internet]. 1986;369:618–20. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2980574
110. Abe H, Koike T, Minakawa T, Tanaka R. [Liquid embolization for arteriovenous malformation with temporary balloon occlusion of another feeders]. Rinsho Hoshasen [Internet]. 1989 Jun;34(6):739–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/2614983
111. Bank WO, Stemer AB, Armonda RA, Bell RS. Intermittent balloon occlusion to favor nidal penetration during embolization of arteriovenous malformations: a technique modification. J Neurointerv Surg [Internet]. 2014 May;6(4):e28–e28. Available from: http://jnis.bmj.com/lookup/doi/10.1136/neurintsurg-2012-010637.rep
112. Pulli B, Sussman ES, Mayercik V, Steinberg GK, Do HM, Heit JJ. Initial experience with the Scepter Mini dual-lumen balloon for transophthalmic artery embolization of anterior cranial fossa dural arteriovenous fistulae. J Neurointerv Surg. 2020;12(11):1132–6.
113. Vollherbst DF, Chapot R, Wallocha M, Saatci I, Cekirge S, Rouchaud A, et al. First clinical multicenter experience with the new Scepter Mini microballoon catheter. J Neurointerv Surg. 2020;1–7.
114. Massoud TF, Hademenos GJ. Transvenous retrograde nidus sclerotherapy under controlled hypotension (TRENSH): a newly proposed treatment for brain arteriovenous malformations--concepts and rationale. Neurosurgery [Internet]. 1999 Aug;45(2):351–63; discussion 363-5. Available from: http://www.ncbi.nlm.nih.gov/pubmed/10449081
115. Choudhri O, Ivan ME, Lawton MT. Transvenous Approach to Intracranial Arteriovenous Malformations: Challenging the Axioms of Arteriovenous Malformation Therapy? Neurosurgery. 2015;77(4):644–51.
116. Chen CJ, Norat P, Ding D, Mendes GAC, Tvrdik P, Park MS, et al. Transvenous embolization of brain arteriovenous malformations: A review of techniques, indications, and outcomes. Neurosurg Focus. 2018;45(1):1–7.
117. Mendes GAC, Kalani MYS, Iosif C, Lucena AF, Carvalho R, Saleme S, et al. Transvenous Curative Embolization of Cerebral Arteriovenous Malformations: A Prospective Cohort Study. Neurosurgery [Internet]. 2017 Dec 21; Available from: http://academic.oup.com/neurosurgery/advance-article/doi/10.1093/neuros/nyx581/4769327
118. Iosif C, Mendes GAC, Saleme S, Ponomarjova S, Silveira EP, Caire F, et al. Endovascular transvenous cure for ruptured brain arteriovenous malformations in complex cases with high Spetzler-Martin grades. J Neurosurg [Internet]. 2015;122(5):1229–38. Available from: https://samba.huji.ac.il/+CSCO+0h756767633A2F2F6775727761662E626574++/doi/full/10.3171/2014.9.JNS141714
119. Mendes GAC, Iosif C, Silveira EP, Waihrich E, Saleme S, Mounayer C. Transvenous Embolization in Pediatric Plexiform Arteriovenous Malformations. Neurosurgery. 2016;78(3):458–65.
120. Kulcsár Z, Machi P, Schaller K, Lovblad KO, Bijlenga P. Trans-venous embolization of a basal ganglia ruptured arteriovenous malformation with open surgical arterial control: A hybrid technique. J Neuroradiol [Internet]. 2018 May;45(3):202–5. Available from: http://linkinghub.elsevier.com/retrieve/pii/S015098611730305X
121. Van Rooij WJ, Jacobs S, Sluzewski M, Beute GN, Van Der Pol B. Endovascular treatment of ruptured brain AVMs in the acute phase of hemorrhage. Am J Neuroradiol. 2012;33(6):162–6.
122. Pierot L, Cognard C, Herbreteau D, Fransen H, Van Rooij WJ, Boccardi E, et al. Endovascular treatment of brain arteriovenous malformations using a liquid embolic agent: Results of a prospective, multicentre study (BRAVO). Eur Radiol. 2013;23(10):2838–45.
123. Pierot L, Januel AC, Herbreteau D, Barreau X, Drouineau J, Berge J, et al. Endovascular Treatment of Brain Arteriovenous Malformations Using Onyx: Preliminary Results of a Prospective Multicenter Study. Interv Neuroradiol [Internet]. 2005 Oct 24;11(1_suppl):159–64. Available from: http://www.centauro-online.it/interventional_pdf/IN_11_3_Dr_Siekmann.pdf.zip%5Cnpapers3://publication/uuid/2095E17D-9797-49A7-BD06-6C7CD75EDCF5
124. Baharvahdat H, Blanc R, Termechi R, Pistocchi S, Bartolini B, Redjem H, et al. Hemorrhagic complications after endovascular treatment of cerebral arteriovenous malformations. AJNR Am J Neuroradiol [Internet]. 2014;35(5):978–83. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24676002
125. Liu L, Jiang C, He H, Li Y, Wu Z. Periprocedural bleeding complications of brain AVM embolization with onyx (Interventional Neuroradiology (2010) 16, (47-57)). Vol. 16, Interventional Neuroradiology. 2010. p. 213.
126. Ledezma CJ, Hoh BL, Carter BS, Pryor JC, Putman CM, Ogilvy CS. Complications of cerebral arteriovenous malformation embolization: Multivariate analysis of predictive factors. Neurosurgery. 2006;58(4):602–10.
127. Crowley RW, Ducruet AF, Kalani MYS, Kim LJ, Albuquerque FC, McDougall CG. Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era. J Neurosurg [Internet]. 2015;122(June):1–6. Available from: https://samba.huji.ac.il/+CSCO+0h756767633A2F2F6775727761662E626574++/doi/full/10.3171/2015.2.JNS131368
128. Elsenousi A, Aletich VA, Alaraj A. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: A meta-analysis. J Neurointerv Surg. 2016;8(3):265–72.

Descargas

Publicado

2021-04-29

Cómo citar

Lozano-Tangua, C. F., Zenteno Castellanos, M., Lee, A., Casasco, A. ., Balderrama Bañares, J. L., Rosero Rosero, J. C., Patiño Rodriguez, H. M. ., Montenegro Rosales, H. A. ., Acosta Fernández, R. C., & Ramirez Ocampo, M. . (2021). EVOLUCIÓN DEL MANEJO ENDOVASCULAR EN MALFORMACIONES ARTERIOVENOSAS CEREBRALES. Neurociencias Journal, 28(1), 76–114. https://doi.org/10.51437/nj.v28i1.183

Número

Sección

Artículo de revisión